Cogent Biosciences

-$0.34 (-3.68%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COGT and other ETFs, options, and stocks.

About COGT

Cogent Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17.

CEO
Andrew R. Robbins
Employees
15
Headquarters
Cambridge, Massachusetts
Founded
2014

COGT Key Statistics

Market Cap
341.85M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
179.71K
High Today
$9.28
Low Today
$8.57
Open Price
$9.28
Volume
201.84K
52 Week High
$14.44
52 Week Low
$5.83

COGT Earnings

-$6.06
-$4.04
-$2.02
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure